Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5:24. https://doi.org/10.1038/s41572-019-0074-3.

Article  PubMed  Google Scholar 

Diallo A, Jacobi H, Tezenas du Montcel S, Klockgether T. Natural history of most common spinocerebellar ataxia a: systematic review and meta-analysis. J Neurol. 2021;268:2749–56. https://doi.org/10.1007/s00415-020-09815-2.

Article  PubMed  Google Scholar 

Yap KH, Azmin S, Che Hamzah J, Ahmad N, van de Warrenburg B, Mohamed IN. Pharmacological and non-pharmacological management of spinocerebellar ataxia: a systematic review. J Neurol. 2022;269:2315–37. https://doi.org/10.1007/s00415-021-10874-2.

Article  PubMed  Google Scholar 

Sullivan R, Yau WY, O’Connor E, Houlden H. Spinocerebellar ataxia: an update. J Neurol. 2019;266:533–44. https://doi.org/10.1007/s00415-018-9076-4.

Article  PubMed  Google Scholar 

Bhandari J, Thada PK, Samanta D. Spinocerebellar Ataxia, StatPearls. Treasure Island (FL). https://www.ncbi.nlm.nih.gov/pubmed/32491748. Accessed 1 Nov 2023.

Teive HAG, Meira AT, Camargo CHF, Munhoz RP. The geographic diversity of spinocerebellar ataxias (SCAs) in the Americas: a systematic review. Mov Disord Clin Pract. 2019;6:531–40. https://doi.org/10.1002/mdc3.12822.

Article  PubMed  PubMed Central  Google Scholar 

Globas C, du Montcel ST, Baliko L, Boesch S, Depondt C, DiDonato S, Durr A, Filla A, Klockgether T, Mariotti C, Melegh B, Rakowicz M, Ribai P, Rola R, Schmitz-Hubsch T, Szymanski S, Timmann D, Van de Warrenburg BP, Bauer P, Schols L. Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Mov Disord. 2008;23:2232–8. https://doi.org/10.1002/mds.22288.

Article  PubMed  Google Scholar 

Diallo A, Jacobi H, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sobanska A, Sulek A, Schmitz-Hübsch T, Schöls L, Hengel H, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Boesch S, Pandolfo M, Schulz JB, Bauer P, Giunti P, Kang JS, Klockgether T, Tezenas du Montcel S. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study. Lancet Neurol. 2018;17:327–34. https://doi.org/10.1016/s1474-4422(18)30042-5.

Article  PubMed  Google Scholar 

Schmitz-Hübsch T, Coudert M, Giunti P, Globas C, Baliko L, Fancellu R, Mariotti C, Filla A, Rakowicz M, Charles P, Ribai P, Szymanski S, Infante J, van de Warrenburg BPC, Dürr A, Timmann D, Boesch S, Rola R, Depondt C, Schöls L, Zdzienicka E, Kang J-S, Ratzka S, Kremer B, Schulz JB, Klopstock T, Melegh B, du Montcel ST, Klockgether T. Self-rated health status in spinocerebellar ataxia—Results from a European multicenter study. Mov Disord. 2010;25:587–95. https://doi.org/10.1002/mds.22740.

Article  PubMed  Google Scholar 

Sanchez-Lopez CR, Perestelo-Perez L, Escobar A, Lopez-Bastida J, Serrano-Aguilar P. Health-related quality of life in patients with spinocerebellar ataxia. Neurologia. 2017;32:143–51. https://doi.org/10.1016/j.nrl.2015.09.002.

Article  CAS  PubMed  Google Scholar 

Ashizawa T, Öz G, Paulson HL. Spinocerebellar ataxias: prospects and challenges for therapy development. Nat Rev Neurol. 2018;14:590–605. https://doi.org/10.1038/s41582-018-0051-6.

Article  PubMed  PubMed Central  Google Scholar 

Stephen CD, Brizzi KT, Bouffard MA, Gomery P, Sullivan SL, Mello J, MacLean J, Schmahmann JD. The comprehensive management of cerebellar ataxia in adults. Curr Treat Options Neurol. 2019;21:9. https://doi.org/10.1007/s11940-019-0549-2.

Article  PubMed  Google Scholar 

Ghanekar SD, Kuo SH, Staffetti JS, Zesiewicz TA. Current and emerging treatment modalities for spinocerebellar ataxias. Expert Rev Neurother. 2022;22:101–14. https://doi.org/10.1080/14737175.2022.2029703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brooker SM, Edamakanti CR, Akasha SM, Kuo SH, Opal P. Spinocerebellar ataxia clinical trials: opportunities and challenges. Ann Clin Transl Neurol. 2021;8:1543–56. https://doi.org/10.1002/acn3.51370.

Article  PubMed  PubMed Central  Google Scholar 

Chen ML, Lin CC, Rosenthal LS, Opal P, Kuo SH. Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development. J Neurol Sci. 2021;424:117417. https://doi.org/10.1016/j.jns.2021.117417.

Article  PubMed  PubMed Central  Google Scholar 

Maas R, van de Warrenburg BPC. Exploring the clinical meaningfulness of the Scale for the Assessment and Rating of Ataxia: a comparison of patient and physician perspectives at the item level. Parkinsonism Relat Disord. 2021;91:37–41. https://doi.org/10.1016/j.parkreldis.2021.08.014.

Article  PubMed  Google Scholar 

Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schöls L, Szymanski S, van de Warrenburg BP, Dürr A, Klockgether T, Fancellu R. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20. https://doi.org/10.1212/01.wnl.0000219042.60538.92.

Article  PubMed  Google Scholar 

Moulaire P, Poulet PE, Petit E, Klockgether T, Durr A, Ashisawa T, Tezenas du Montcel S. Temporal dynamics of the Scale for the Assessment and Rating of Ataxia in spinocerebellar ataxias. Mov Disord. 2023;38:35–44. https://doi.org/10.1002/mds.29255.

Article  PubMed  Google Scholar 

Sarro L, Nanetti L, Castaldo A, Mariotti C. Monitoring disease progression in spinocerebellar ataxias: implications for treatment and clinical research. Expert Rev Neurother. 2017;17:919–31. https://doi.org/10.1080/14737175.2017.1364628.

Article  CAS  PubMed  Google Scholar 

ClinicalTrials.gov. (NCT03701399) Troriluzole in Adult Subjects With Spinocerebellar Ataxia. https://classic.clinicaltrials.gov/show/NCT03701399. Accessed September 19 2023.

Beiner M, Wirtz V, L’Italien G, Ruggiero L, Berman R, Coric V. Analysis of 96 week, long-term open label extension phase of study BHV4157-201: a phase IIb/III, randomized, double-blind, placebo-controlled trial of the safety and efficacy of troriluzole in adult subjects with spinocerebellar ataxia (2837). Neurology. 2021;96:2837.

Article  Google Scholar 

US Food and Drug Administration. Patient-Focused Drug Development Guidance Public Workshop: Incorporating Clinical Outcome Assessments Into Endpoints For Regulatory Decision-Making. 2019, April. Available at: https://www.fda.gov/media/132505/download?attachment. Accessed Nov 1 2023.

US Food and Drug Administration. Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making: Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. 2023, April. Available at: https://www.fda.gov/media/166830/download. Accessed Nov 1 2023.

US Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. US Food and Drug Administration; 2009, December. Available at: https://www.fda.gov/media/77832/download. Accessed Nov 1 2023.

Schmahmann JD, Pierce S, MacMore J, L’Italien GJ. Development and validation of a patient-reported outcome measure of ataxia. Mov Disord. 2021;36:2367–77. https://doi.org/10.1002/mds.28670.

Article  PubMed  Google Scholar 

Klockgether T, Ludtke R, Kramer B, Abele M, Burk K, Schols L, Riess O, Laccone F, Boesch S, Lopes-Cendes I, Brice A, Inzelberg R, Zilber N, Dichgans J. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain. 1998;121(Pt 4):589–600. https://doi.org/10.1093/brain/121.4.589.

Article  PubMed  Google Scholar 

McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4:293–307. https://doi.org/10.1007/bf01593882.

Article  CAS  PubMed  Google Scholar 

Nunnally JC, Bernstein IH. Psychometric theory. New York: McGraw-Hill New York; 1994.

Google Scholar 

Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6:284–90. https://doi.org/10.1037/1040-3590.6.4.284

Subramony SH, May W, Lynch D, Gomez C, Fischbeck K, Hallett M, Taylor P, Wilson R, Ashizawa T. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology. 2005;64:1261–2. https://doi.org/10.1212/01.WNL.0000156802.15466.79.

Article  CAS  PubMed  Google Scholar 

Gershon RC, Lai JS, Bode R, Choi S, Moy C, Bleck T, Miller D, Peterman A, Cella D. Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res. 2012;21:475–86. https://doi.org/10.1007/s11136-011-9958-8.

Article  PubMed  Google Scholar 

Schmahmann JD, Gardner R, MacMore J, Vangel MG. Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS. Mov Disord. 2009;24:1820–8. https://doi.org/10.1002/mds.22681.

Article  PubMed  PubMed Central  Google Scholar 

Beck AT, Steer RA, Brown G. Beck Depression Inventory–II. PsycTESTS Dataset. 1996. https://doi.org/10.1037/t00742-000.

Article  Google Scholar 

Beck AT, Epstein N, Brown G,